临床试验

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

NCT：NCT07816185 · RECRUITING

NCT编号NCT07816185

状态RECRUITING

开始日期2026-08-31

完成时间2029-08-31

SponsorPulmovant, Inc. (INDUSTRY)

First posted2026-09-11

Last updated2026-09-11

简要摘要

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。